Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Aruni Mulgirigama, MBBS

Global Medical Affairs Lead
GlaxoSmithKline plc., United Kingdom

Disclosure(s): GlaxoSmithKline plc.: Employee and shareholder, GlaxoSmithKline plc.-sponsored study 212502

Poster(s):

2225 - Analysis of Co-Resistance Among Escherichia coli Urine Isolates From Female Outpatients in the United States
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET
2226 - Analysis of Co-Resistance Among Klebsiella pneumoniae Urine Isolates From Female Outpatients in the United States
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET
2227 - Prevalence, Regional Distribution, and Trends of Antimicrobial Resistance Among Female Outpatients With Urine Klebsiella pneumoniae Isolates: A Multicenter Evaluation
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET